Citius Pharmaceuticals Inc (NASDAQ:CTXR) collaborated with the University of Pittsburgh for I/ONTAK (denileukin diftitox or E7777) in combination with Merck & Company,…
September 22, 1:42 PM
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
September 22, 7:22 AM
Nanobiotix (NASDAQ: NBTX) determined the recommended phase 2 dose (RP2D) of the NBTXR3 combo regime for inoperable locoregional recurrent or recurrent and metastatic head and neck squamous cell carcinoma that is resistant to prior immunotherapy.
September 22, 6:43 AM
Merck (NYSE:MRK), known as MSD outside of the United States and Canada, announced today that the U.S. District Court for the Northern District of West Virginia ruled in favor of the company in a patent infringement suit
September 18, 3:25 PM
As we move further into the second half of the year, many investors will find themselves repositioning to better allocate their investments to mitigate risks. Some investors prefer to take positions in equities that hedge funds are buying, as large institutional ownership can create more demand for shares.
Qurient Announces Collaboration Agreement With MSD To Evaluate Selective CDK7 Inhibitor Q901 In Combination With KEYTRUDA
September 14, 5:05 PM
September 14, 1:44 PM
Someone with a lot of money to spend has taken a bullish stance on Merck & Co (NYSE:MRK). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.
September 14, 10:07 AM
Upgrades For Iris Energy Ltd (NASDAQ:IREN), Compass Point upgraded the previous rating of Neutral to Buy. The current stock performance of Iris Energy shows a 52-week-high of $17.97 and a 52-week-low of $2.89. Moreover, at the end of the last trading period, the closing price was at $4.26.